140 related articles for article (PubMed ID: 19148840)
1. Metabolic syndrome and cardiometabolic risk: an update.
Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Bombelli M; Mancia G
Blood Press; 2009; 18(1-2):7-16. PubMed ID: 19148840
[TBL] [Abstract][Full Text] [Related]
2. Obesity and cardiometabolic syndrome in children.
Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
Grassi G
Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and target organ damage: role of blood pressure.
Cuspidi C; Sala C; Zanchetti A
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):731-43. PubMed ID: 18510489
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
Ganne S; Arora S; Karam J; McFarlane SI
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665
[TBL] [Abstract][Full Text] [Related]
7. The cardiometabolic syndrome in the adolescent.
Gardner M; Gardner DW; Sowers JR
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of metabolic syndrome and cardiovascular risk among police personnel compared to general population in India.
Tharkar S; Kumpatla S; Muthukumaran P; Viswanathan V
J Assoc Physicians India; 2008 Nov; 56():845-9. PubMed ID: 19263681
[TBL] [Abstract][Full Text] [Related]
9. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand.
Tanomsup S; Aekplakorn W; Sritara P; Woodward M; Yamwong S; Tunlayadechanont S; Tatsaneeyapan A; Lim S; Rajatanavin R
Diabetes Care; 2007 Aug; 30(8):2138-40. PubMed ID: 17468343
[No Abstract] [Full Text] [Related]
10. Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world.
Margozzini P; Rigotti A; Ferreccio C; Quezada N; Garrido M; Valdés G
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):83-90. PubMed ID: 19124397
[TBL] [Abstract][Full Text] [Related]
11. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome.
Grassi G; Arenare F; Quarti-Trevano F; Seravalle G; Mancia G
Prog Cardiovasc Dis; 2009; 52(1):31-7. PubMed ID: 19615491
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
Worm SW; Friis-Møller N; Bruyand M; D'Arminio Monforte A; Rickenbach M; Reiss P; El-Sadr W; Phillips A; Lundgren J; Sabin C;
AIDS; 2010 Jan; 24(3):427-35. PubMed ID: 19910787
[TBL] [Abstract][Full Text] [Related]
13. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
14. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
Ren J; Kelley RO
Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
[TBL] [Abstract][Full Text] [Related]
15. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
Krentz AJ; Clough G; Byrne CD
J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
[TBL] [Abstract][Full Text] [Related]
16. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
Frohlich ED
J Cardiometab Syndr; 2008; 3(3):147-8. PubMed ID: 18983330
[No Abstract] [Full Text] [Related]
17. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
Schindler C
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
[TBL] [Abstract][Full Text] [Related]
18. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
Battista M; Murray RD; Daniels SR
Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
[TBL] [Abstract][Full Text] [Related]
19. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic syndrome as cardiovascular risk factor].
Dłuzniewski M; Mamcarz A
Kardiol Pol; 2005 Jun; 62 Suppl 2():II28-9. PubMed ID: 19813332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
